These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10965959)

  • 1. European hepatitis B immunoglobulin trials: prevention of recurrent hepatitis B after liver transplantation.
    Krüger M
    Clin Transplant; 2000; 14 Suppl 2():14-9. PubMed ID: 10965959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens.
    Anderson RD; Chinnakotla S; Guo L; Perrillo RP; Klintmalm GB; Davis GL
    Clin Transplant; 2007; 21(4):510-7. PubMed ID: 17645711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immune globulin: the US experience.
    Pruett TL; McGory R
    Clin Transplant; 2000; 14 Suppl 2():7-13. PubMed ID: 10965958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.
    al-Hemsi B; McGory RW; Shepard B; Ishitani MB; Stevenson WC; McCullough C; Pruett TL
    Clin Transplant; 1996 Dec; 10(6 Pt 2):668-75. PubMed ID: 8996763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
    Han SH; Martin P; Edelstein M; Hu R; Kunder G; Holt C; Saab S; Durazo F; Goldstein L; Farmer D; Ghobrial RM; Busuttil RW
    Liver Transpl; 2003 Feb; 9(2):182-7. PubMed ID: 12548512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases.
    de Man RA; Metselaar HJ; Heijtink RA; Schalm SW
    Neth J Med; 1993 Aug; 43(1-2):74-82. PubMed ID: 8232699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B recurrence after liver transplantation: efficacy and safety of intramuscular anti-hepatitis B immunoglobulins].
    Marzano A
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1 Suppl 1):1-17. PubMed ID: 23570102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
    Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H
    Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged administration of hepatitis B hyperimmune gamma globulin in patients with liver transplantation in liver diseases caused by hepatitis B virus].
    Restrepo JC; Rimola A; Mas A; Navasa M; Salmerón JM; Cirera I; García-Valdecasas JC; Grande L; Visa J; Rodés J
    Gastroenterol Hepatol; 1996 Dec; 19(10):491-6. PubMed ID: 9044746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Sánchez-Fueyo A; Rimola A; Grande L; Costa J; Mas A; Navasa M; Cirera I; Sánchez-Tapias JM; Rodés J
    Hepatology; 2000 Feb; 31(2):496-501. PubMed ID: 10655276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic analysis of HBV liver transplant therapies.
    McGory R
    Clin Transplant; 2000; 14 Suppl 2():29-38. PubMed ID: 10965962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatitis B: the con aspect.
    Wiesner RH; Krom RA
    Liver Transpl Surg; 1995 Jul; 1(4):265-70. PubMed ID: 9346580
    [No Abstract]   [Full Text] [Related]  

  • 17. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
    Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
    Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
    Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW
    Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: hepatitis B and liver transplantation.
    Mutimer D
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1031-41. PubMed ID: 16611263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.